Literature DB >> 3022415

The platelet reactivity of collagen type I: evidence for multiple platelet-reactive sites in the type I collagen molecule.

C M Fitzsimmons, T E Cawston, M J Barnes.   

Abstract

In this study, the ability of peptides, obtained by fragmentation of the collagen type I molecule, to induce platelet aggregation has been examined. In order to satisfy requirements for tertiary and quaternary structure, peptides were first renatured (where necessary) to restore triple-helical configuration and then polymerised. Fragmentation with mammalian collagenase indicated the presence of platelet-reactive sites in both the N-terminal three-quarter and C-terminal one quarter fragment of the collagen molecule. Cleavage with cyanogen bromide indicated the presence in the constituent alpha 1(I)-chain of at least four platelet-reactive sites. Our results suggest a relatively wide distribution of platelet-binding sites situated throughout the length of the collagen (type I) molecule, each probably of relatively low affinity and low structural specificity, at least in terms of amino acid sequence, and probably of a similar nature to those that might be expected to exist in any collagen-like species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022415

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.

Authors:  R W Farndale; A B Winkler; B R Martin; M J Barnes
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

2.  Conformation-dependent platelet adhesion to collagen involving integrin alpha 2 beta 1-mediated and other mechanisms: multiple alpha 2 beta 1-recognition sites in collagen type I.

Authors:  L F Morton; A R Peachey; L S Zijenah; A H Goodall; M J Humphries; M J Barnes
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

3.  Platelet adhesion to collagen. Factors affecting Mg2(+)-dependent and bivalent-cation-independent adhesion.

Authors:  L S Zijenah; L F Morton; M J Barnes
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  In vitro enhancement of human platelet aggregation by somatostatin.

Authors:  P P Gazzaniga; G Di Macco; R La Mancusa; A Oddi; G Pappalardo; F M Pulcinelli; D Reggio
Journal:  Experientia       Date:  1988-10-15

5.  Platelet-reactive sites in collagen. Collagens I and III possess different aggregatory sites.

Authors:  L F Morton; C M Fitzsimmons; J Rauterberg; M J Barnes
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

6.  Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites.

Authors:  L F Morton; A R Peachey; M J Barnes
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

7.  Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.

Authors:  Susan R Wilson; Christoph Peters; Paul Saftig; Dieter Brömme
Journal:  J Biol Chem       Date:  2008-11-21       Impact factor: 5.157

8.  Mapping of potent and specific binding motifs, GLOGEN and GVOGEA, for integrin α1β1 using collagen toolkits II and III.

Authors:  Samir W Hamaia; Nicholas Pugh; Nicolas Raynal; Benjamin Némoz; Rachael Stone; Donald Gullberg; Dominique Bihan; Richard W Farndale
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

9.  Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in cell--collagen interactions: identification of conformation dependent alpha 1 beta 1 binding sites in collagen type I.

Authors:  D Gullberg; K R Gehlsen; D C Turner; K Ahlén; L S Zijenah; M J Barnes; K Rubin
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

10.  Identification of a major GpVI-binding locus in human type III collagen.

Authors:  Gavin E Jarvis; Nicolas Raynal; Jonathan P Langford; David J Onley; Allen Andrews; Peter A Smethurst; Richard W Farndale
Journal:  Blood       Date:  2008-02-27       Impact factor: 22.113

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.